{ "metadata": { "name": "Counterfeit Ozempic Lot Numbers: Official Alert Identifier Register", "identifier": "wpg-counterfeit-ozempic-identifiers-2026-08-03", "version": "1.0.2", "creator": "Weight Loss Provider Guide Editorial Team", "publisher": "Weight Loss Provider Guide Research", "canonical_page": "https://weightlossproviderguide.com/research/counterfeit-ozempic-lot-numbers/", "last_verified": "2026-08-03", "scope": "Exact Ozempic identifier strings named in publicly accessible official counterfeit-related, suspected-falsification, recall, or market-irregularity notices located under the published methodology through August 3, 2026. All records concern injectable or pre-filled-pen presentations described by the notices.", "headline_counts": { "total_unique_identifier_strings": 30, "group_A": 21, "group_B": 6, "group_C": 3 }, "interpretation_rule": "A lot-number match alone does not prove counterfeit status, and absence from the register does not prove authenticity. Apply every serial, label, market, expiry, carton/pen, device, or relabeling condition in the source alert.", "limitations": [ "Not exhaustive of every counterfeit product or non-public investigation.", "No-match does not establish authenticity.", "A match does not establish counterfeit status unless the full alert condition also matches.", "The dataset counts public identifier strings, not counterfeit units or prevalence.", "Packaging and authorized presentations vary by market.", "Some regulator-to-regulator records provide limited public incident detail.", "The dataset cannot authenticate an individual medicine." ] }, "records": [ { "identifier": "MP5A370", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Not established in the accessible public notice.", "exact_alert_condition_or_interpretation_rule": "Named in a COFEPRIS-origin falsification notice relayed by DIGEMID. The accessible public relay does not provide a safe visual authentication rule.", "market_or_detection_context": "Mexico-origin notice; Peru relay", "official_alert_dates": "2023-09-15 (relays 2023-08-25 COFEPRIS notice)", "testing_or_contents": "", "primary_source_agencies": "Peru DIGEMID, relaying a COFEPRIS notification", "primary_source_urls": "https://www.digemid.minsa.gob.pe/Archivos/Alertas/2023/ALERTA_90-23.pdf", "source_keys": "DIGEMID_90", "last_verified": "2026-08-03", "publication_note": "Removed expiry details that came only from a regulator-restricted surveillance request." }, { "identifier": "MP5B060", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Not established.", "exact_alert_condition_or_interpretation_rule": "Confirmed falsified. One relabeled sample was identified as an Apidra SoloStar pen and laboratory testing found insulin glulisine.", "market_or_detection_context": "Nigeria-origin notification relayed by Peru; Egypt awareness material", "official_alert_dates": "2023-08-22; 2024-01", "testing_or_contents": "One tested relabeled sample contained insulin glulisine.", "primary_source_agencies": "Peru Dirección General de Medicamentos, Insumos y Drogas (DIGEMID) | Egyptian Drug Authority (EDA) | Egyptian Drug Authority (EDA)", "primary_source_urls": "https://www.digemid.minsa.gob.pe/Archivos/Alertas/2023/ALERTA_81-23.pdf | https://edaegypt.gov.eg/media/i3immnu4/%D8%AE%D8%B7%D8%A7%D8%A8-%D8%AA%D9%88%D8%B9%D9%8A%D8%A9-%D8%B1%D9%82%D9%85-1-%D9%84%D8%B3%D9%86%D8%A9-2024-1.pdf | https://edaegypt.gov.eg/media/0krjjxs4/ozempic-%D8%A7%D9%84%D8%B9%D8%A8%D9%88%D8%A9-%D8%A7%D9%84%D9%85%D9%82%D9%84%D8%AF%D8%A9.pdf", "source_keys": "DIGEMID_81 | EDA_2024 | EDA_PHOTOS_2024", "last_verified": "2026-08-03", "publication_note": "Do not generalize the insulin finding to every counterfeit product." }, { "identifier": "MP5C960", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Not established.", "exact_alert_condition_or_interpretation_rule": "Named as falsified in a COFEPRIS notification relayed by DIGEMID; public product-level detail is limited.", "market_or_detection_context": "Mexico-origin notice; Peru relay", "official_alert_dates": "2023-09-15 (relays 2023-08-25 COFEPRIS notice)", "testing_or_contents": "", "primary_source_agencies": "Peru DIGEMID, relaying a COFEPRIS notification", "primary_source_urls": "https://www.digemid.minsa.gob.pe/Archivos/Alertas/2023/ALERTA_90-23.pdf", "source_keys": "DIGEMID_90", "last_verified": "2026-08-03", "publication_note": "" }, { "identifier": "MP5D600", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Not established.", "exact_alert_condition_or_interpretation_rule": "Named as falsified in a COFEPRIS notification relayed by DIGEMID; public product-level detail is limited.", "market_or_detection_context": "Mexico-origin notice; Peru relay", "official_alert_dates": "2023-09-15 (relays 2023-08-25 COFEPRIS notice)", "testing_or_contents": "", "primary_source_agencies": "Peru DIGEMID, relaying a COFEPRIS notification", "primary_source_urls": "https://www.digemid.minsa.gob.pe/Archivos/Alertas/2023/ALERTA_90-23.pdf", "source_keys": "DIGEMID_90", "last_verified": "2026-08-03", "publication_note": "Removed expiry and country details not supported by the accessible public alert." }, { "identifier": "MP5A064", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Not established.", "exact_alert_condition_or_interpretation_rule": "Listed as counterfeit in an official SÚKL regulator-to-regulator bulletin attributed to Brazil; underlying public product detail was not located.", "market_or_detection_context": "Brazilian authority record relayed by Czech regulator", "official_alert_dates": "2024-02", "testing_or_contents": "", "primary_source_agencies": "Czech State Institute for Drug Control (SÚKL)", "primary_source_urls": "https://sukl.gov.cz/wp-content/uploads/2025/02/Vestnik_SUKL_02_2024_new_kor1-1.pdf", "source_keys": "SUKL_02_2024", "last_verified": "2026-08-03", "publication_note": "" }, { "identifier": "LP6F832", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Not recognized as a valid lot by the manufacturer in the cited alerts.", "exact_alert_condition_or_interpretation_rule": "Identifier match is a strong alert signal. Anvisa’s notice showed expiry 11/2025; final authentication still belongs to the pharmacy, regulator or manufacturer.", "market_or_detection_context": "Brazil; WHO Americas/Europe alert; Colombia", "official_alert_dates": "2023-11-03; 2024-06-19; 2024-07-08", "testing_or_contents": "", "primary_source_agencies": "Brazil Agência Nacional de Vigilância Sanitária (Anvisa) | World Health Organization (WHO) | Colombia Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Invima)", "primary_source_urls": "https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2023/anvisa-alertasobre-falsificacao-dos-medicamentos-tysabri-r-e-ozempic-r | https://www.who.int/news/item/19-06-2024-medical-product-alert-n-2-2024--falsified-ozempic-%28semaglutide%29 | https://app.invima.gov.co/alertas/ckfinder/userfiles/files/ALERTAS%20SANITARIAS/medicamentos_pbiologicos/2024/Julio/Alerta%20No_%20%23200-2024%20-%20OZEMPIC%C2%AE%20%281_34%20MG_ML%29%20%E2%80%93%20SEMAGLUTIDA%20Lotes%20LP6F832%2C%20MP5E511%2C%20NAR0074%2C%20NP5G443%20%20%281%29.pdf", "source_keys": "ANVISA_2023 | WHO | INVIMA_2024", "last_verified": "2026-08-03", "publication_note": "" }, { "identifier": "MP5E511", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Authentic batch number; the cited products were falsified.", "exact_alert_condition_or_interpretation_rule": "Apply the incident-specific condition: Poland identified serial 1946483405690; WHO described German-market packaging; Mexico later found MP5E511 on a pen inside a JS7A925 carton.", "market_or_detection_context": "European/UK supply-chain incidents; Colombia; Mexico", "official_alert_dates": "2023-10-12; 2024-06-19; 2024-07-08; 2026-03-26", "testing_or_contents": "Mexico reported no active ingredient in its 2026 carton/pen-mismatch configuration.", "primary_source_agencies": "Poland Chief Pharmaceutical Inspectorate | World Health Organization (WHO) | Colombia Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Invima) | Mexico Federal Commission for Protection against Health Risks (COFEPRIS) | UK Medicines and Healthcare products Regulatory Agency (MHRA)", "primary_source_urls": "https://rdg.ezdrowie.gov.pl/pobierz-decyzje/55e85a84-6299-48e4-9d9a-fe574bad970e | https://www.who.int/news/item/19-06-2024-medical-product-alert-n-2-2024--falsified-ozempic-%28semaglutide%29 | https://app.invima.gov.co/alertas/ckfinder/userfiles/files/ALERTAS%20SANITARIAS/medicamentos_pbiologicos/2024/Julio/Alerta%20No_%20%23200-2024%20-%20OZEMPIC%C2%AE%20%281_34%20MG_ML%29%20%E2%80%93%20SEMAGLUTIDA%20Lotes%20LP6F832%2C%20MP5E511%2C%20NAR0074%2C%20NP5G443%20%20%281%29.pdf | https://www.gob.mx/cms/uploads/attachment/file/1067535/Alerta_Sanitaria_OZEMPiC_26032026.pdf | https://assets.publishing.service.gov.uk/media/669fc22dfc8e12ac3edb02d5/FOI2024_00052_redacted.pdf", "source_keys": "POLAND_2023 | WHO | INVIMA_2024 | COFEPRIS_2026_03 | MHRA_FOI_2024", "last_verified": "2026-08-03", "publication_note": "Never label the entire authentic batch counterfeit." }, { "identifier": "NP5G866", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Lot-wide status not established by the public decision.", "exact_alert_condition_or_interpretation_rule": "The Polish decision identified exact combinations with serial 1946483405690 or 1031002838555 and expiry 12/2025.", "market_or_detection_context": "Poland/European legal supply chain", "official_alert_dates": "2023-10-12", "testing_or_contents": "", "primary_source_agencies": "Poland Chief Pharmaceutical Inspectorate | UK Medicines and Healthcare products Regulatory Agency (MHRA)", "primary_source_urls": "https://rdg.ezdrowie.gov.pl/pobierz-decyzje/55e85a84-6299-48e4-9d9a-fe574bad970e | https://assets.publishing.service.gov.uk/media/669fc22dfc8e12ac3edb02d5/FOI2024_00052_redacted.pdf", "source_keys": "POLAND_2023 | MHRA_FOI_2024", "last_verified": "2026-08-03", "publication_note": "Do not classify every NP5G866 pack as counterfeit." }, { "identifier": "NAR0074", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "The lot-and-serial combination does not correspond to genuine manufacturing records.", "exact_alert_condition_or_interpretation_rule": "Exact serial number 430834149057 must accompany NAR0074.", "market_or_detection_context": "United States; WHO alert; Colombia", "official_alert_dates": "2023-12-21; 2024-06-19; 2024-07-08", "testing_or_contents": "FDA confirmed counterfeit needles, pen label, carton and accompanying information in sampled product.", "primary_source_agencies": "U.S. Food and Drug Administration (FDA) | World Health Organization (WHO) | Colombia Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Invima)", "primary_source_urls": "https://www.fda.gov/drugs/drug-alerts-and-statements/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain | https://www.who.int/news/item/19-06-2024-medical-product-alert-n-2-2024--falsified-ozempic-%28semaglutide%29 | https://app.invima.gov.co/alertas/ckfinder/userfiles/files/ALERTAS%20SANITARIAS/medicamentos_pbiologicos/2024/Julio/Alerta%20No_%20%23200-2024%20-%20OZEMPIC%C2%AE%20%281_34%20MG_ML%29%20%E2%80%93%20SEMAGLUTIDA%20Lotes%20LP6F832%2C%20MP5E511%2C%20NAR0074%2C%20NP5G443%20%20%281%29.pdf", "source_keys": "FDA | WHO | INVIMA_2024", "last_verified": "2026-08-03", "publication_note": "" }, { "identifier": "NPSG234", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Not a genuine Ozempic batch number.", "exact_alert_condition_or_interpretation_rule": "Match the exact identifier and the physical inconsistencies described by TGA.", "market_or_detection_context": "Australia border detection", "official_alert_dates": "2024-09-30; updated 2025-01-23", "testing_or_contents": "Laboratory testing found undeclared insulin glulisine.", "primary_source_agencies": "Australia Therapeutic Goods Administration (TGA)", "primary_source_urls": "https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/counterfeit-ozempic-pens-detected-and-adverse-event-reported", "source_keys": "TGA_2024", "last_verified": "2026-08-03", "publication_note": "" }, { "identifier": "JS7A925", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Not a genuine Ozempic batch number in the Australian incident.", "exact_alert_condition_or_interpretation_rule": "Australia: identifier printed on a counterfeit pen. Mexico 2026: JS7A925 on the carton, MP5E511 on the pen, with different expiries.", "market_or_detection_context": "Australia; Thai-authority relay; Mexico", "official_alert_dates": "2024-07-26; 2024-09-30; 2026-03-26", "testing_or_contents": "Australia found insulin glulisine; Mexico reported no active ingredient in its separate configuration.", "primary_source_agencies": "Australia Therapeutic Goods Administration (TGA) | Czech State Institute for Drug Control (SÚKL), relaying the Thai authority | Mexico Federal Commission for Protection against Health Risks (COFEPRIS)", "primary_source_urls": "https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/counterfeit-ozempic-pens-detected-and-adverse-event-reported | https://sukl.gov.cz/zavady-v-jakosti/padelky-v-legalnim-distribucnim-retezci/informace-o-vyskytu-padelku-leciveho-pripravku-ozempic-6/?lang=1 | https://www.gob.mx/cms/uploads/attachment/file/1067535/Alerta_Sanitaria_OZEMPiC_26032026.pdf", "source_keys": "TGA_2024 | SUKL_THAI | COFEPRIS_2026_03", "last_verified": "2026-08-03", "publication_note": "Keep the incidents separate because their contents differed." }, { "identifier": "NP5G443", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "The pen described by Invima was not genuine.", "exact_alert_condition_or_interpretation_rule": "Invima described another product’s pen relabeled and boxed as Ozempic 0.25/0.5 mg.", "market_or_detection_context": "Colombia", "official_alert_dates": "2024-07-08", "testing_or_contents": "Contents not publicly determined in the reviewed notice.", "primary_source_agencies": "Colombia Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Invima)", "primary_source_urls": "https://app.invima.gov.co/alertas/ckfinder/userfiles/files/ALERTAS%20SANITARIAS/medicamentos_pbiologicos/2024/Julio/Alerta%20No_%20%23200-2024%20-%20OZEMPIC%C2%AE%20%281_34%20MG_ML%29%20%E2%80%93%20SEMAGLUTIDA%20Lotes%20LP6F832%2C%20MP5E511%2C%20NAR0074%2C%20NP5G443%20%20%281%29.pdf", "source_keys": "INVIMA_2024", "last_verified": "2026-08-03", "publication_note": "" }, { "identifier": "MPSD916", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Not a genuine Ozempic batch number.", "exact_alert_condition_or_interpretation_rule": "TGA identified typographic inconsistencies, including differences in spacing and bolding.", "market_or_detection_context": "Australia border detection", "official_alert_dates": "2025-04-03", "testing_or_contents": "", "primary_source_agencies": "Australia Therapeutic Goods Administration (TGA)", "primary_source_urls": "https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/counterfeit-ozempic-injection-pens-detected", "source_keys": "TGA_2025", "last_verified": "2026-08-03", "publication_note": "" }, { "identifier": "PAR0362", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Authentic lot number.", "exact_alert_condition_or_interpretation_rule": "Counterfeit condition is PAR0362 paired with a serial number beginning with the first eight digits 51746517.", "market_or_detection_context": "United States legitimate drug supply chain", "official_alert_dates": "2025-04-14", "testing_or_contents": "", "primary_source_agencies": "U.S. Food and Drug Administration (FDA) | Novo Nordisk", "primary_source_urls": "https://www.fda.gov/drugs/drug-alerts-and-statements/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain | https://www.ozempic.com/content/dam/novomedlink/semaglutide/04-14-25-company-statement.pdf", "source_keys": "FDA | NOVO_PAR0362", "last_verified": "2026-08-03", "publication_note": "Lot alone is insufficient." }, { "identifier": "PAR1229", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Authentic lot number.", "exact_alert_condition_or_interpretation_rule": "Counterfeit pen: EXP/LOT text is left of the expiration date and lot number. Authentic pen: EXP/LOT text is above them.", "market_or_detection_context": "United States legitimate drug supply chain", "official_alert_dates": "2025-12-05", "testing_or_contents": "", "primary_source_agencies": "U.S. Food and Drug Administration (FDA)", "primary_source_urls": "https://www.fda.gov/drugs/drug-alerts-and-statements/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain", "source_keys": "FDA", "last_verified": "2026-08-03", "publication_note": "Lot alone is insufficient." }, { "identifier": "NP5K174", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Original and authentic Ozempic lot.", "exact_alert_condition_or_interpretation_rule": "Anvisa reported signs that labels may have been removed from authentic Ozempic pens and reused on Fiasp insulin pens; the fraud investigation was ongoing.", "market_or_detection_context": "Brazil", "official_alert_dates": "2024-10-29", "testing_or_contents": "The substituted pen may be Fiasp insulin; no public final laboratory result was located in the notice.", "primary_source_agencies": "Brazil Agência Nacional de Vigilância Sanitária (Anvisa) | Czech State Institute for Drug Control (SÚKL)", "primary_source_urls": "https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-alertasobre-falsificacao-do-medicamento-ozempic-r | https://sukl.gov.cz/wp-content/uploads/2024/12/Mesicni-informace-11-2024.pdf", "source_keys": "ANVISA_2024 | SUKL_11_2024", "last_verified": "2026-08-03", "publication_note": "Use investigation language, not a definitive lot-wide claim." }, { "identifier": "PP5L609", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Not established.", "exact_alert_condition_or_interpretation_rule": "Listed as counterfeit in a SÚKL regulator-to-regulator bulletin attributed to Brazil; no public product-level recognition rule was located.", "market_or_detection_context": "Brazilian authority record relayed by Czech regulator", "official_alert_dates": "2024-11", "testing_or_contents": "", "primary_source_agencies": "Czech State Institute for Drug Control (SÚKL)", "primary_source_urls": "https://sukl.gov.cz/wp-content/uploads/2024/12/Mesicni-informace-11-2024.pdf", "source_keys": "SUKL_11_2024", "last_verified": "2026-08-03", "publication_note": "" }, { "identifier": "MG5B070", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Not established.", "exact_alert_condition_or_interpretation_rule": "MALMED reported it in a falsified-product notice; a later Thai-authority update relayed by SÚKL listed it among identifiers suspected of counterfeiting.", "market_or_detection_context": "North Macedonia; Thai-authority relay", "official_alert_dates": "2023-10-31; 2024-07-26", "testing_or_contents": "", "primary_source_agencies": "North Macedonia Agency for Medicines and Medical Devices (MALMED) | Czech State Institute for Drug Control (SÚKL), relaying the Thai authority", "primary_source_urls": "https://malmed.gov.mk/wp-content/uploads/%D0%9E%D0%B7%D0%B5%D0%BC%D0%BF%D0%B8%D0%BA-%D1%84%D0%B0%D0%BB%D1%81%D0%B8%D1%84%D0%B8%D0%BA%D1%83%D0%B2%D0%B0%D0%BD-%D0%BB%D0%B5%D0%BA.pdf | https://sukl.gov.cz/zavady-v-jakosti/padelky-v-legalnim-distribucnim-retezci/informace-o-vyskytu-padelku-leciveho-pripravku-ozempic-6/?lang=1", "source_keys": "MALMED_2023 | SUKL_THAI", "last_verified": "2026-08-03", "publication_note": "Preserve both authorities’ status language." }, { "identifier": "MP5D775", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Not established.", "exact_alert_condition_or_interpretation_rule": "Reported in MALMED’s falsified Ozempic notice; public incident detail is limited.", "market_or_detection_context": "North Macedonia", "official_alert_dates": "2023-10-31", "testing_or_contents": "", "primary_source_agencies": "North Macedonia Agency for Medicines and Medical Devices (MALMED)", "primary_source_urls": "https://malmed.gov.mk/wp-content/uploads/%D0%9E%D0%B7%D0%B5%D0%BC%D0%BF%D0%B8%D0%BA-%D1%84%D0%B0%D0%BB%D1%81%D0%B8%D1%84%D0%B8%D0%BA%D1%83%D0%B2%D0%B0%D0%BD-%D0%BB%D0%B5%D0%BA.pdf", "source_keys": "MALMED_2023", "last_verified": "2026-08-03", "publication_note": "" }, { "identifier": "PP5K617", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Authentic lot intended for Colombia; counterfeit configurations can copy it.", "exact_alert_condition_or_interpretation_rule": "Mexico 2025: authentic Colombia-market lot not authorized for sale in Mexico. Mexico 2026: counterfeit 0.25–0.5 mg presentation, expiry 08/2026, whose pen differed from the genuine FlexTouch device.", "market_or_detection_context": "Mexico; intended market Colombia", "official_alert_dates": "2025-06-17; 2026-05-25", "testing_or_contents": "", "primary_source_agencies": "Mexico Federal Commission for Protection against Health Risks (COFEPRIS) | Mexico Federal Commission for Protection against Health Risks (COFEPRIS)", "primary_source_urls": "https://www.gob.mx/cms/uploads/attachment/file/1002514/Alerta_Sanitaria_Ozempic_17062025.pdf | https://www.gob.mx/cms/uploads/attachment/file/1080351/Alerta_Sanitaria_OZEMPiC_25052026.pdf", "source_keys": "COFEPRIS_2025 | COFEPRIS_2026_05", "last_verified": "2026-08-03", "publication_note": "Do not label every PP5K617 unit counterfeit." }, { "identifier": "PP7K381", "record_class": "A — confirmed, regulator-reported, or actively investigated counterfeit/falsified/non-genuine configuration", "lot_authenticity_or_validity": "Reported by COFEPRIS as nonexistent in company records in any market.", "exact_alert_condition_or_interpretation_rule": "Match the exact identifier and the presentation in the Mexican alert; expiry shown 10/2026.", "market_or_detection_context": "Mexico", "official_alert_dates": "2025-06-17", "testing_or_contents": "", "primary_source_agencies": "Mexico Federal Commission for Protection against Health Risks (COFEPRIS)", "primary_source_urls": "https://www.gob.mx/cms/uploads/attachment/file/1002514/Alerta_Sanitaria_Ozempic_17062025.pdf", "source_keys": "COFEPRIS_2025", "last_verified": "2026-08-03", "publication_note": "" }, { "identifier": "MP5D558", "record_class": "B — suspected or precautionarily recalled; no public final confirmation located", "lot_authenticity_or_validity": "Not established.", "exact_alert_condition_or_interpretation_rule": "EDA warned of possible packs not belonging to or manufactured by the company, said it had not detected them locally as of the notice, and linked a package-comparison sheet. No later public final disposition was located.", "market_or_detection_context": "Egypt", "official_alert_dates": "2024-01", "testing_or_contents": "", "primary_source_agencies": "Egyptian Drug Authority (EDA) | Egyptian Drug Authority (EDA)", "primary_source_urls": "https://edaegypt.gov.eg/media/i3immnu4/%D8%AE%D8%B7%D8%A7%D8%A8-%D8%AA%D9%88%D8%B9%D9%8A%D8%A9-%D8%B1%D9%82%D9%85-1-%D9%84%D8%B3%D9%86%D8%A9-2024-1.pdf | https://edaegypt.gov.eg/media/0krjjxs4/ozempic-%D8%A7%D9%84%D8%B9%D8%A8%D9%88%D8%A9-%D8%A7%D9%84%D9%85%D9%82%D9%84%D8%AF%D8%A9.pdf", "source_keys": "EDA_2024 | EDA_PHOTOS_2024", "last_verified": "2026-08-03", "publication_note": "Suspected only; the awareness letter did not report a local detection or final case disposition." }, { "identifier": "PP5N682::RN287", "record_class": "B — suspected or precautionarily recalled; no public final confirmation located", "lot_authenticity_or_validity": "Not established.", "exact_alert_condition_or_interpretation_rule": "One parallel-imported pack was suspected to be falsified and recalled at patient level as a precaution. Preserve the full printed batch identifier and expiry 02/2027.", "market_or_detection_context": "Malta", "official_alert_dates": "2025-08-11", "testing_or_contents": "", "primary_source_agencies": "Malta Medicines Authority", "primary_source_urls": "https://medicinesauthority.gov.mt/file.aspx?f=7536", "source_keys": "MALTA_PDF_2025", "last_verified": "2026-08-03", "publication_note": "Do not shorten to PP5N682 or describe it as confirmed." }, { "identifier": "MP58060", "record_class": "B — suspected or precautionarily recalled; no public final confirmation located", "lot_authenticity_or_validity": "Not established.", "exact_alert_condition_or_interpretation_rule": "Named exactly as printed among identifiers suspected of counterfeiting in a Thai-authority update relayed by SÚKL.", "market_or_detection_context": "Thai-authority relay; not reported supplied in Czech market", "official_alert_dates": "2024-07-26", "testing_or_contents": "", "primary_source_agencies": "Czech State Institute for Drug Control (SÚKL), relaying the Thai authority", "primary_source_urls": "https://sukl.gov.cz/zavady-v-jakosti/padelky-v-legalnim-distribucnim-retezci/informace-o-vyskytu-padelku-leciveho-pripravku-ozempic-6/?lang=1", "source_keys": "SUKL_THAI", "last_verified": "2026-08-03", "publication_note": "" }, { "identifier": "MP58058", "record_class": "B — suspected or precautionarily recalled; no public final confirmation located", "lot_authenticity_or_validity": "Not established.", "exact_alert_condition_or_interpretation_rule": "Named exactly as printed among identifiers suspected of counterfeiting in a Thai-authority update relayed by SÚKL.", "market_or_detection_context": "Thai-authority relay; not reported supplied in Czech market", "official_alert_dates": "2024-07-26", "testing_or_contents": "", "primary_source_agencies": "Czech State Institute for Drug Control (SÚKL), relaying the Thai authority", "primary_source_urls": "https://sukl.gov.cz/zavady-v-jakosti/padelky-v-legalnim-distribucnim-retezci/informace-o-vyskytu-padelku-leciveho-pripravku-ozempic-6/?lang=1", "source_keys": "SUKL_THAI", "last_verified": "2026-08-03", "publication_note": "" }, { "identifier": "MP4B060", "record_class": "B — suspected or precautionarily recalled; no public final confirmation located", "lot_authenticity_or_validity": "Not established.", "exact_alert_condition_or_interpretation_rule": "Named exactly as printed among identifiers suspected of counterfeiting in a Thai-authority update relayed by SÚKL.", "market_or_detection_context": "Thai-authority relay; not reported supplied in Czech market", "official_alert_dates": "2024-07-26", "testing_or_contents": "", "primary_source_agencies": "Czech State Institute for Drug Control (SÚKL), relaying the Thai authority", "primary_source_urls": "https://sukl.gov.cz/zavady-v-jakosti/padelky-v-legalnim-distribucnim-retezci/informace-o-vyskytu-padelku-leciveho-pripravku-ozempic-6/?lang=1", "source_keys": "SUKL_THAI", "last_verified": "2026-08-03", "publication_note": "Do not conflate with MP5B060." }, { "identifier": "HP5C989", "record_class": "B — suspected or precautionarily recalled; no public final confirmation located", "lot_authenticity_or_validity": "Not established.", "exact_alert_condition_or_interpretation_rule": "Named exactly as printed among identifiers suspected of counterfeiting in a Thai-authority update relayed by SÚKL.", "market_or_detection_context": "Thai-authority relay; not reported supplied in Czech market", "official_alert_dates": "2024-07-26", "testing_or_contents": "", "primary_source_agencies": "Czech State Institute for Drug Control (SÚKL), relaying the Thai authority", "primary_source_urls": "https://sukl.gov.cz/zavady-v-jakosti/padelky-v-legalnim-distribucnim-retezci/informace-o-vyskytu-padelku-leciveho-pripravku-ozempic-6/?lang=1", "source_keys": "SUKL_THAI", "last_verified": "2026-08-03", "publication_note": "" }, { "identifier": "PP5M797", "record_class": "C — authentic foreign-market lot flagged for unauthorized commercialization only", "lot_authenticity_or_validity": "Authentic lot intended for Colombia.", "exact_alert_condition_or_interpretation_rule": "COFEPRIS named the lot because it was not authorized for commercialization in Mexico; expiry shown 04/2027. This fact alone is not evidence of falsification.", "market_or_detection_context": "Mexico; intended market Colombia", "official_alert_dates": "2025-06-17", "testing_or_contents": "", "primary_source_agencies": "Mexico Federal Commission for Protection against Health Risks (COFEPRIS)", "primary_source_urls": "https://www.gob.mx/cms/uploads/attachment/file/1002514/Alerta_Sanitaria_Ozempic_17062025.pdf", "source_keys": "COFEPRIS_2025", "last_verified": "2026-08-03", "publication_note": "Keep separate from counterfeit and suspected records." }, { "identifier": "PP5L232", "record_class": "C — authentic foreign-market lot flagged for unauthorized commercialization only", "lot_authenticity_or_validity": "Authentic lot intended for Colombia.", "exact_alert_condition_or_interpretation_rule": "COFEPRIS named the lot because it was not authorized for commercialization in Mexico; expiry shown 12/2026. This fact alone is not evidence of falsification.", "market_or_detection_context": "Mexico; intended market Colombia", "official_alert_dates": "2025-06-17", "testing_or_contents": "", "primary_source_agencies": "Mexico Federal Commission for Protection against Health Risks (COFEPRIS)", "primary_source_urls": "https://www.gob.mx/cms/uploads/attachment/file/1002514/Alerta_Sanitaria_Ozempic_17062025.pdf", "source_keys": "COFEPRIS_2025", "last_verified": "2026-08-03", "publication_note": "Keep separate from counterfeit and suspected records." }, { "identifier": "PP5L843", "record_class": "C — authentic foreign-market lot flagged for unauthorized commercialization only", "lot_authenticity_or_validity": "Authentic lot intended for Colombia.", "exact_alert_condition_or_interpretation_rule": "COFEPRIS named the lot because it was not authorized for commercialization in Mexico; expiry shown 01/2027. This fact alone is not evidence of falsification.", "market_or_detection_context": "Mexico; intended market Colombia", "official_alert_dates": "2025-06-17", "testing_or_contents": "", "primary_source_agencies": "Mexico Federal Commission for Protection against Health Risks (COFEPRIS)", "primary_source_urls": "https://www.gob.mx/cms/uploads/attachment/file/1002514/Alerta_Sanitaria_Ozempic_17062025.pdf", "source_keys": "COFEPRIS_2025", "last_verified": "2026-08-03", "publication_note": "Keep separate from counterfeit and suspected records." } ] }